Übersetzung für "Stable angina" in Deutsch

In chronic stable angina, these symptoms appear during physical effort.

In stable angina, these symptoms occur during physical effort.

In stable angina, these symptoms appear during physical effort.

With stable angina, the dosage of the drug is as follows:

There is stable angina and patients should not be given beta-blockers;

Also, this drug is prescribed for therapy for vasospastic and stable angina.

Less certain is how to manage stable angina in older people.

With stable angina, the initial volume of coriol is 12.5 mg 2 times a day.

Generic Cartia is used for treating high blood pressure and chronic stable angina (chest pain).

Those with stable angina develop the symptoms gradually over time.

Stable angina pectoris: prevents the occurrence of seizures, increases the tolerance of stress;

There are two types of angina – stable and unstable.

But finally every patient with a stable angina pectoris is a candidate for CSWT.

The half-life of 6 to 8 hours permits twice daily dosage, and total-daily dosages between 10 and 40 mg have been effective in patients with chronic stable angina.

Felodipine improves exercise tolerance and reduces anginal attacks in patients with stable effort-induced angina pectoris.

Procoralan has been studied in five main studies involving over 4,000 adults with long-term stable angina.

Amlodipine has been studied in patients with chronic stable angina, vasospastic angina and angiographically documented coronary artery disease.

Corlentor is used to treat the symptoms of chronic stable angina pectoris (pains to the chest, jaw, back, brought on by physical effort, and due to problems with the blood flow to the heart).

The Committee for Medicinal products for Human Use (CHMP) concluded that Corlentor has sufficient effectiveness against angina, and an acceptable safety profile, for Corlentor to provide an alternative treatment for patients with chronic stable angina pectoris with normal sinus rhythm who cannot take beta-blockers.

Symptomatic treatment of chronic stable angina pectoris in patients with normal sinus rhythm, who have a contra-indication or intolerance for beta-blockers.

These trials included a total of 3,222 patients with chronic stable angina pectoris, of whom 2,168 received ivabradine.

The Committee for Medicinal Products for Human Use (CHMP) noted that the effectiveness of Ranexa in improving the symptoms of patients with stable angina pectoris is modest but that it could be of value in patients who have not responded fully to other medicines for angina pectoris.

No clinical relevant differences were demonstrated in time to limiting angina for sildenafil when compared with placebo in a double blind, placebo controlled exercise stress trial in 144 patients with erectile dysfunction and chronic stable angina, who were taking on a regular basis anti-anginal medications (except nitrates).